William Arcese

Qualifica
ORDINARIO
Fonte dei dati: Archivio della Ricerca http://art.torvergata.it
  1. Buccisano, F., Palmieri, R., Piciocchi, A., Arena, V., Candoni, A., Melillo, L., et al. (2021). ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol. BLOOD ADVANCES [10.1182/bloodadvances.2021005717]. Dettagli
  2. Bekadja, M., Boumendil, A., Blaise, D., Chevallier, P., Peggs, K.S., Salles, G., et al. (2021). Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry. CYTOTHERAPY, 23(6), 483-487-487 [10.1016/j.jcyt.2020.12.016]. Dettagli
  3. Mikulska, M., Tridello, G., Hoek, J., Gil, L., Yañez, L., Labussière-Wallet, H., et al. (2021). Legionellosis after hematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION [10.1038/s41409-021-01333-7]. Dettagli
  4. Hayden, P.J., Eikema, D., de Wreede, L.C., Koster, L., Kröger, N., Einsele, H., et al. (2021). Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party. BONE MARROW TRANSPLANTATION [10.1038/s41409-021-01286-x]. Dettagli
  5. Buccisano, F., Palmieri, R., Piciocchi, A., Maurillo, L., Del Principe, M.I., Paterno, G., et al. (2021). Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation. CANCERS [10.3390/cancers13051083]. Dettagli
  6. Cesaro, S., Tridello, G., Knelange, N.S., Blijlevens, N., Martin, M., Snowden, J.A., et al. (2021). Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT. BONE MARROW TRANSPLANTATION [10.1038/s41409-021-01212-1]. Dettagli
  7. Domingo-Domenech, E., Duarte, R.F., Boumedil, A., Onida, F., Gabriel, I., Finel, H., et al. (2021). Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. BONE MARROW TRANSPLANTATION. Dettagli
  8. Battipaglia, G., Mauff, K., Wendel, L., Angelucci, E., Mohty, M., Arcese, W., et al. (2021). Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT. BONE MARROW TRANSPLANTATION, 56(7), 1593-1602-1602 [10.1038/s41409-021-01222-z]. Dettagli
  9. Fabiani, E., Cicconi, L., Nardozza, A.M., Cristiano, A., Rossi, M., Ottone, T., et al. (2021). Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia. CANCER MEDICINE, 10(12), 3839-3847 [10.1002/cam4.3904]. Dettagli
  10. Nagler, A., Kanate, A.S., Labopin, M., Ciceri, F., Angelucci, E., Koc, Y., et al. (2021). Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia. HAEMATOLOGICA, 106(6), 1591-1598 [10.3324/haematol.2020.247296]. Dettagli
  11. Picardi, A., Sacchi, N., Miotti, V., Lorentino, F., Oldani, E., Rambaldi, A., et al. (2021). Allelic HLA matching and pair origin are favorable prognostic factors for unrelated hematopoietic stem cell transplantation in neoplastic hematologic diseases: an Italian analysis by the Gruppo italiano trapianto di cellule staminali e terapie cellulari, Italian bone marrow donor registry, and Associazione Italiana di immunogenetica e biologia dei trapianti. TRANSPLANTATION AND CELLULAR THERAPY, 27(5), 406.e1-406.e11 [10.1016/j.jtct.2020.11.021]. Dettagli
  12. De Bellis, E., Ottone, T., Mercante, L., Falconi, G., Cugini, E., Consalvo, M.I., et al. (2020). Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia. LEUKEMIA RESEARCH, 99, 106462. Dettagli
  13. Castagna, L., Busca, A., Bramanti, S., Raiola Anna, M., Malagola, M., Ciceri, F., et al. (2020). Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients. BMC CANCER, 20(1), 1140. Dettagli
  14. Travaglini, S., Angelini, D.F., Alfonso, V., Guerrera, G., Lavorgna, S., Divona, M., et al. (2020). Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells. BLOOD CANCER JOURNAL, 10(8), 85. Dettagli
  15. Gurnari, C., Breccia, M., Di Giuliano, F., Scalzulli, E., Divona, M., Piciocchi, A., et al. (2020). Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters. BRITISH JOURNAL OF HAEMATOLOGY. Dettagli
  16. Meconi, F., Provenzano, I., Nasso, D., Mariotti, B., Pupo, L., Secchi, R., et al. (2020). A case of metachronous peripheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin. CLINICAL CASE REPORTS, 8(8), 1353-1356. Dettagli
  17. Arcese, W., Cerretti, R., Sarmati, L., Cudillo, L., De Angelis, G., Mariotti, B., et al. (2020). MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2020.02.005]. Dettagli
  18. Gilleece, M.H., Labopin, M., Savani, B.N., Yakoub-Agha, I., Socie, G., Gedde-Dahl, T., et al. (2020). Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT. LEUKEMIA, 34(1), 87-99 [10.1038/s41375-019-0527-4]. Dettagli
  19. Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., et al. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(12), 2388-2397-2397 [10.1016/j.bbmt.2019.07.037]. Dettagli
  20. Del Principe, M.i., Venditti, A., Arcese, W., Cantonetti, M., Buccisano, F., Maurillo, L., et al. (2019). DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 11(1), 1-8. Dettagli
  21. Noguera, N.I., Catalano, G., Banella, C., Divona, M., Faraoni, I., Ottone, T., et al. (2019). Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies. CANCERS, 11(10), 1591 [10.3390/cancers11101591]. Dettagli
  22. Venditti, A., Piciocchi, A., Candoni, A., Melillo, L., Calafiore, V., Cairoli, R., et al. (2019). GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia. BLOOD, 134(12), 935-945. Dettagli
  23. Iaccarino, L., Ottone, T., Alfonso, V., Cicconi, L., Divona, M., Lavorgna, S., et al. (2019). Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse. AMERICAN JOURNAL OF HEMATOLOGY, 94(10), 1091-1097. Dettagli
  24. Derenzini, E., Risso, A., Ruella, M., Spatola, T., Milone, G., Pioltelli, P., et al. (2019). INFLUENCE OF DONOR AND RECIPIENT GENDER ON TELOMERE MAINTENANCE FOLLOWING UMBILICAL CORD BLOOD CELL TRANSPLANTATION: A STUDY BY GITMO (GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2019.03.026]. Dettagli
  25. Bazarbachi, A., Labopin, M., Battipaglia, G., Djabali, A., Passweg, J., Socié, G., et al. (2019). Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of EBMT acute leukemia Working Party. HAEMATOLOGICA, 104(9), haematol.2018.211615 [10.3324/haematol.2018.211615]. Dettagli
  26. Alfonso, V., Iaccarino, L., Ottone, T., Cicconi, L., Lavorgna, S., Divona, M., et al. (2019). Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia. LEUKEMIA. Dettagli
  27. Amadori, S., Arcese, W., Avvisati, G., Gale, R.P., & Lo-Coco, F. (2019). Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931- July 15, 2018. LEUKEMIA, 33(2), 285-286 [10.1038/s41375-018-0352-1]. Dettagli
  28. Bove, P., Iacovelli, V., Tirindelli, M.c., Bianchi, D., Flammia, G.p., Cipriani, C., et al. (2019). Endoscopic intravesical fibrin glue application in the treatment of refractory hemorrhagic radiation cystitis: A single cohort pilot study. JOURNAL OF ENDOUROLOGY, 33(2), 93-98 [10.1089/end.2018.0028]. Dettagli
  29. Marchesi, F., Pimpinelli, F., Di Domenico, E.G., Renzi, D., Gallo, M.T., Regazzo, G., et al. (2019). Association between CMV and invasive fungal infections after autologous stem cell transplant in lymphoproliferative malignancies: Opportunistic partnership or cause-effect relationship?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(6), 1373 [10.3390/ijms20061373]. Dettagli
  30. Meconi, F., Ciangola, G., Mariotti, B., Cerretti, R., Cudillo, L., Arcese, W., et al. (2019). Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor. CASE REPORT IN INFECTIOUS DISEASES, 2019, 4603130. Dettagli
  31. Piemontese, S., Boumendil, A., Labopin, M., Schmid, C., Ciceri, F., Arcese, W., et al. (2019). Leukemia relapse following unmanipulated haploidentical transplantation: A risk factor analysis on behalf of the ALWP of the EBMT. JOURNAL OF HEMATOLOGY & ONCOLOGY, 12(1), 68 [10.1186/s13045-019-0751-4]. Dettagli
  32. Santoro, N., Labopin, M., Ciceri, F., Van Lint, M.t., Nasso, D., Blaise, D., et al. (2019). Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age and over. CANCER [10.1002/cncr.31941]. Dettagli
  33. Tendas, A., Marchesi, F., Mengarelli, A., Annibali, O., Tomarchio, V., Saltarelli, D., et al. (2019). Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions. SUPPORTIVE CARE IN CANCER, 27(3), 793-803 [10.1007/s00520-018-4594-2]. Dettagli
  34. Ottone, T., Alfonso, V., Iaccarino, L., Hasan, S.K., Mancini, M., Divona, M., et al. (2018). Longitudinal detection of DNMT3AR882Htranscripts in patients with acute myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY. Dettagli
  35. Bove, P., Iacovelli, V., Cipriani, C., Tirindelli Maria, C., Flammia Gerardo, P., Cindolo, L., et al. (2018). ENDOSCOPIC INTRAVESICAL FIBRIN GLUE APPLICATION IN THE TREATMENT OF REFRACTORY HAEMORRHAGIC RADIATION CYSTITIS. Paper presented at Anticancer Research. Dettagli
  36. Buccisano, F., Maurillo, L., Del Principe, M.I., Di Veroli, A., De Bellis, E., Biagi, A., et al. (2018). Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia. EXPERT REVIEW OF HEMATOLOGY, 11(4), 307-313. Dettagli
  37. Canaani, J., Labopin, M., Huang, X.-., Arcese, W., Ciceri, F., Blaise, D., et al. (2018). T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. AMERICAN JOURNAL OF HEMATOLOGY, 93(6), 736-744 [10.1002/ajh.25082]. Dettagli
  38. Canaani, J., Savani, B.n., Labopin, M., Huang, X.-., Ciceri, F., Arcese, W., et al. (2018). Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. AMERICAN JOURNAL OF HEMATOLOGY, 93(2), 246-253 [10.1002/ajh.24963]. Dettagli
  39. Del Principe, M.I., Buccisano, F., Soddu, S., Maurillo, L., Cefalo, M., Piciocchi, A., et al. (2018). Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome. SEMINARS IN HEMATOLOGY. Dettagli
  40. Gagelmann, N., Eikema, D., Iacobelli, S., Koster, L., Nahi, H., Stoppa, A., et al. (2018). Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the Chronic Malignancies Working Party of the EBMT. HAEMATOLOGICA [10.3324/haematol.2017.178434]. Dettagli
  41. Picardi, A., Sacchi, N., Miotti, V., Lorentino, F., Oldani, E., Rambaldi, A., et al. (2018). High resolution donor/recipient HLA matching level in unrelated hematopoietic stem cell transplantation and impact on the transplant outcome: the Italian experience on behalf of GITMO, IBMDR and Aibt. BLOOD, 132(Supplement 1), 4642-4642. Dettagli
  42. Salvatore, D., Labopin, M., Ruggeri, A., Battipaglia, G., Ghavamzadeh, A., Ciceri, F., et al. (2018). Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute leukemia working party of the european society for blood and marrow transplantation. HAEMATOLOGICA, 103(8), 1317-1328 [10.3324/haematol.2018.189258]. Dettagli
  43. Saraceni, F., Beohou, E., Labopin, M., Arcese, W., Bonifazi, F., Stepensky, P., et al. (2018). Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY, 93(10), 1211-1219 [10.1002/ajh.25225]. Dettagli
  44. Tendas, A., Malandruccolo, L., Venditti, D., Costa, A., Volta, L., Annibali, O., et al. (2018). Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series. ANNALS OF PALLIATIVE MEDICINE, 7(4), 484-486 [10.21037/apm.2018.04.03]. Dettagli
  45. Vago, L., Toffalori, C., Ahci, M., Lange, V., Lang, K., Todaro, S., et al. (2018). Incidence of HLA loss in a global multicentric cohort of post-transplantation relapses: results from the Hlaloss Collaborative Study. BLOOD, 132(Supplement 1), 818-818. Dettagli
  46. Lorentino, F., Labopin, M., Fleischhauer, K., Ciceri, F., Mueller, C.r., Ruggeri, A., et al. (2017). The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis. BLOOD ADVANCES, 1(11), 669-680 [10.1182/bloodadvances.2017006429]. Dettagli
  47. Buccisano, F., Maurillo, L., Piciocchi, A., Del Principe, M.i., Picardi, A., Cerretti, R., et al. (2017). Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia. BONE MARROW TRANSPLANTATION, 52(3), 473-475 [10.1038/bmt.2016.308]. Dettagli
  48. Canaani, J., Savani, B., Labopin, M., Huang, X., Ciceri, F., Arcese, W., et al. (2017). Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the acute leukemia working party of the EBMT. HAEMATOLOGICA, 102(6), 1066-1074 [10.3324/haematol.2016.160804]. Dettagli
  49. Cefalo, M., DEL PRINCIPE, M.I., Buccisano, F., Di Piazza, F., OTTAVIANI, L., Maurillo, L., et al. (2017). Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients. ANNALS OF HEMATOLOGY & ONCOLOGY, 4(4), 1-5. Dettagli
  50. De Bellis, E., Fianchi, L., Buccisano, F., Criscuolo, M., Maurillo, L., Cicconi, L., et al. (2017). Treatment of low-blast count AML using hypomethylating agents. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 9(1), e2017045. Dettagli
  51. Eder, S., Beohou, E., Labopin, M., Sanz, J., Finke, J., Arcese, W., et al. (2017). Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. AMERICAN JOURNAL OF HEMATOLOGY, 92(1), 18-22 [10.1002/ajh.24567]. Dettagli
  52. Eder, S., Canaani, J., Beohou, E., Labopin, M., Sanz, J., Arcese, W., et al. (2017). Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. AMERICAN JOURNAL OF HEMATOLOGY, 92(10), 997-1003 [10.1002/ajh.24823]. Dettagli
  53. Girmenia, C., Bertaina, A., Piciocchi, A., Perruccio, K., Algarotti, A., Busca, A., et al. (2017). Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. CLINICAL INFECTIOUS DISEASES, 65(11), 1884-1896 [10.1093/cid/cix690]. Dettagli
  54. Gorin, N., Labopin, M., Czerw, T., Pabst, T., Blaise, D., Dumas, P., et al. (2017). Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission—Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). CANCER, 123(5), 824-831 [10.1002/cncr.30400]. Dettagli
  55. Marchesi, F., Tendas, A., Giannarelli, D., Viggiani, C., Gumenyuk, S., Renzi, D., et al. (2017). Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study. BONE MARROW TRANSPLANTATION, 52(1), 154-156 [10.1038/bmt.2016.207]. Dettagli
  56. Paviglianiti, A., Ruggeri, A., Volt, F., Sanz, G., Milpied, N., Furst, S., et al. (2017). Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies. BRITISH JOURNAL OF HAEMATOLOGY [10.1111/bjh.14962]. Dettagli
  57. Picardi, A., Arcese, W., Pollichieni, S., Di Piazza, F., Mangione, I., Gallina, A.m., et al. (2017). The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy. TRANSFUSION, 57(7), 1734-1743 [10.1111/trf.14131]. Dettagli
  58. Picardi, A., Ferraro, A.S., Miranda, M., Meconi, F., Lanti, A., Adorno, G., et al. (2017). Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation. ORAL & IMPLANTOLOGY, 10(4), 398-405 [10.11138/orl/2017.10.4.398]. Dettagli
  59. Picardi, A., Miranda, M., Liciani, F., Paterno, G., Arcese, W., & Bollero, P. (2017). Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation. ORAL & IMPLANTOLOGY, 10(4), 390-397 [10.11138/orl/2017.10.4.390]. Dettagli
  60. Piemontese, S., Ciceri, F., Labopin, M., ARCESE, W., Kyrcz Krzemien, S., Santarone, S., et al. (2017). A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia. JOURNAL OF HEMATOLOGY & ONCOLOGY, 10(1), 1-8 [10.1186/s13045-017-0394-2]. Dettagli
  61. Ruggeri, A., Sun, Y., Labopin, M., Bacigalupo, A., Lorentino, F., Arcese, W., et al. (2017). Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant. HAEMATOLOGICA, 102(2), 401-410 [10.3324/haematol.2016.151779]. Dettagli
  62. Saraceni, F., Bruno, B., Lemoli, R.m., Meloni, G., Arcese, W., Falda, M., et al. (2017). Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission. BONE MARROW TRANSPLANTATION, 52(1), 163-166 [10.1038/bmt.2016.233]. Dettagli
  63. Sarmati, L., Andreoni, M., Antonelli, G., Arcese, W., Bruno, R., Coppola, N., et al. (2017). Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper. CLINICAL MICROBIOLOGY AND INFECTION, 23(12), 935-940 [10.1016/j.cmi.2017.06.023]. Dettagli
  64. Scarlata, S., Annibali, O., Santangelo, S., Tomarchio, V., Ferraro, S., Armiento, D., et al. (2017). Pulmonary complications and survival after autologous stem cell transplantation: Predictive role of pulmonary function and pneumotoxic medications. EUROPEAN RESPIRATORY JOURNAL, 49(3), 1601902 [10.1183/13993003.01902-2016]. Dettagli
  65. Shouval, R., Ruggeri, A., Labopin, M., Mohty, M., Sanz, G., Michel, G., et al. (2017). An integrative scoring system for survival prediction following umbilical cord blood transplantation in acute leukemia. CLINICAL CANCER RESEARCH, 23(21), 6478-6486 [10.1158/1078-0432.CCR-17-0489]. Dettagli
  66. Todisco, E., Ciceri, F., Boschini, C., Giglio, F., Bacigalupo, A., Patriarca, F., et al. (2017). Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO). BONE MARROW TRANSPLANTATION [10.1038/bmt.2016.325]. Dettagli
  67. Del Principe, M.I., Buccisano, F., Maurillo, L., Sconocchia, G., Cefalo, M., Consalvo, M., et al. (2016). Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 8(1), e2016052 [10.4084/MJHID.2016.052]. Dettagli
  68. Cerva, C., Colagrossi, L., Maffongelli, G., Salpini, R., Di Carlo, D., Malagnino, V., et al. (2016). Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. CLINICAL MICROBIOLOGY AND INFECTION, 22(11), 946.e1-946.e8 [10.1016/j.cmi.2016.07.021]. Dettagli
  69. Rocha, V., Ruggeri, A., Spellman, S., Wang, T., Sobecks, R., Locatelli, F., et al. (2016). Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(7), 1284-1289 [10.1016/j.bbmt.2016.04.007]. Dettagli
  70. De Felice, L., AGOSTINI, F., Suriano, C., Fraboni, D., Gregorj, C., Tirindelli, M., et al. (2016). Hematopoietic, Mesenchymal, and Immune Cells Are More Enhanced in Bone Marrow than in Peripheral Blood from Granulocyte Colony-Stimulating Factor Primed Healthy Donors. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2016.06.024]. Dettagli
  71. Tendas, A., Cupelli, L., Mauroni, M.r., Sollazzo, F., Di Piazza, F., Saltarelli, D., et al. (2016). Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy?. CANCER, 122(9), 1461-1462 [10.1002/cncr.29943]. Dettagli
  72. Gratwohl, A., Iacobelli, S., Bootsman, N., van Biezen, A., Baldomero, H., Arcese, W., et al. (2016). Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. ANNALS OF HEMATOLOGY, 95(6), 967-972 [10.1007/s00277-016-2638-6]. Dettagli
  73. Tendas, A., Cupelli, L., Mauroni, M.R., Sollazzo, F., Di Piazza, F., Saltarelli, D., et al. (2016). Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network. BONE MARROW TRANSPLANTATION, 51(5), 638-639 [10.1038/bmt.2015.341]. Dettagli
  74. Piñana, J.l., Sanz, J., Esquirol, A., Martino, R., Picardi, A., Barba, P., et al. (2016). Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease. EUROPEAN JOURNAL OF HAEMATOLOGY [10.1111/ejh.12557]. Dettagli
  75. Renzi, D., Marchesi, F., De Angelis, G., Elia, L., Salvatorelli, E., Gumenyuk, S., et al. (2016). Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant. CHEMOTHERAPY, 62(1), 58-61 [10.1159/000448750]. Dettagli
  76. Rubio, M.t., Savani, B.n., Labopin, M., Piemontese, S., Polge, E., Ciceri, F., et al. (2016). Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT. JOURNAL OF HEMATOLOGY & ONCOLOGY, 9(1), 25 [10.1186/s13045-016-0248-3]. Dettagli
  77. Saraceni, F., Labopin, M., Gorin, N., Blaise, D., Tabrizi, R., Volin, L., et al. (2016). Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT. JOURNAL OF HEMATOLOGY & ONCOLOGY, 9(1), 79 [10.1186/s13045-016-0314-x]. Dettagli
  78. Mengarelli, A., Annibali, O., Pimpinelli, F., Riva, E., Gumenyuk, S., Renzi, D., et al. (2015). Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant. JOURNAL OF INFECTION, 72(2), 265-268 [10.1016/j.jinf.2015.11.005]. Dettagli
  79. Rambaldi, A., Grassi, A., Masciulli, A., Boschini, C., Micò, M.c., Busca, A., et al. (2015). Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. THE LANCET ONCOLOGY, 16(15), 1525-36 [10.1016/S1470-2045(15)00200-4]. Dettagli
  80. Marchand, T., Lamy, T., Finel, H., Arcese, W., Choquet, S., Finke, J., et al. (2015). Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. LEUKEMIA, 30(5), 1201-1204 [10.1038/leu.2015.256]. Dettagli
  81. Ruggeri, A., Labopin, M., Sanz, G., Piemontese, S., Arcese, W., Bacigalupo, A., et al. (2015). Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. LEUKEMIA, 29(9), 1891-1900 [10.1038/leu.2015.98]. Dettagli
  82. Ringdén, O., Labopin, M., Ciceri, F., Velardi, A., Bacigalupo, A., Arcese, W., et al. (2015). Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?. LEUKEMIA, 30(2), 447-455 [10.1038/leu.2015.232]. Dettagli
  83. Tendas, A., Niscola, P., Perrotti, A., Dentamaro, T., de Fabritiis, P., & Arcese, W. (2015). Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need. SUPPORTIVE CARE IN CANCER, 23(8), 2211-2211 [10.1007/s00520-015-2711-z]. Dettagli
  84. Arcese, W., Picardi, A., Santarone, S., De Angelis, G., Cerretti, R., Cudillo, L., et al. (2015). Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update. BONE MARROW TRANSPLANTATION, 50 Suppl 2, S24-S30 [10.1038/bmt.2015.91]. Dettagli
  85. Piemontese, S., Ciceri, F., Labopin, M., Bacigalupo, A., Huang, H., Santarone, S., et al. (2015). A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia. LEUKEMIA, 29(5), 1069-1075 [10.1038/leu.2014.336]. Dettagli
  86. Gorin, N., Labopin, M., Piemontese, S., Arcese, W., Santarone, S., Huang, H., et al. (2015). T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis. HAEMATOLOGICA, 100(4), 558-564 [10.3324/haematol.2014.111450]. Dettagli
  87. Marchesi, F., Cerchiara, E., Dessanti, M.L., Gumenyuk, S., Franceschini, L., Palombi, F., et al. (2015). Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network. BRITISH JOURNAL OF HAEMATOLOGY, 169(2), 293-296 [10.1111/bjh.13199]. Dettagli
  88. Eder, S., Labopin, M., Arcese, W., Or, R., Majolino, I., Bacigalupo, A., et al. (2015). Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY, 96(1), 90-97 [10.1111/ejh.12553]. Dettagli
  89. Ronci, C., Ferraro, A.S., Lanti, A., Missiroli, F., Sinopoli, S., Del Proposto, G., et al. (2015). Platelet-rich plasma as treatment for persistent ocular epithelial defects. TRANSFUSION AND APHERESIS SCIENCE, 52(3), 300-304 [10.1016/j.transci.2014.12.027]. Dettagli
  90. Maurillo, L., Buccisano, F., Piciocchi, A., Del Principe, M.I., Sarlo, C., Di Veroli, A., et al. (2014). Minimal Residual Disease as Biomarker for Optimal Biologic Dosing of ARA-C in Patients with Acute Myeloid Leukemia. AMERICAN JOURNAL OF HEMATOLOGY [10.1002/ajh.23893]. Dettagli
  91. Duarte, R.F., Boumendil, A., Onida, F., Gabriel, I., Arranz, R., Arcese, W., et al. (2014). Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis. JOURNAL OF CLINICAL ONCOLOGY, 32(29), 3347-3348 [10.1200/JCO.2014.57.5597]. Dettagli
  92. Tirindelli, M., Flammia, G., Bove, P., Cerretti, R., Cudillo, L., De Angelis, G., et al. (2014). Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(10), 1612-1617 [10.1016/j.bbmt.2014.06.018]. Dettagli
  93. Kharfan-Dabaja, M.A., Labopin, M., Bazarbachi, A., Hamladji, R.M., Blaise, D., Socié, G., et al. (2014). Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT. BONE MARROW TRANSPLANTATION, 49(9), 1170-1175 [10.1038/bmt.2014.133]. Dettagli
  94. Patriarca, F., Luznik, L., Medeot, M., Zecca, M., Bacigalupo, A., Di Bartolomeo, P., et al. (2014). Experts' considerations on HLA-haploidentical stem cell transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY, 93(3), 187-197 [10.1111/ejh.12322]. Dettagli
  95. Ruggeri, A., Labopin, M., Sormani, M.P., Sanz, G., Sanz, J., Volt, F., et al. (2014). Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. HAEMATOLOGICA, 99(9), 1509-1515 [10.3324/haematol.2014.109280]. Dettagli
  96. Tucunduva, L., Ruggeri, A., Sanz, G., Furst, S., Cornelissen, J., Linkesch, W., et al. (2014). Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation. BRITISH JOURNAL OF HAEMATOLOGY, 166(5), 749-757 [10.1111/bjh.12970]. Dettagli
  97. Girmenia, C., Barosi, G., Piciocchi, A., ARCESE, W., Aversa, F., Bacigalupo, A., et al. (2014). Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(8), 1080-1088 [10.1016/j.bbmt.2014.02.018]. Dettagli
  98. Nagler, A., Labopin, M., Gorin, N., Ferrara, F., Sanz, M.A., Wu, D., et al. (2014). Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. HAEMATOLOGICA, 99(8), 1380-1386 [10.3324/haematol.2014.105197]. Dettagli
  99. Testi, M., Andreani, M., Locatelli, F., Arcese, W., Troiano, M., Battarra, M., et al. (2014). Influence of the HLA characteristics of Italian patients on donor search outcome in unrelated hematopoietic stem cell transplantation. TISSUE ANTIGENS, 84(2), 198-205 [10.1111/tan.12355]. Dettagli
  100. Tucunduva, L., Ruggeri, A., Sanz, G., Furst, S., Socié, G., Michallet, M., et al. (2014). Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. BONE MARROW TRANSPLANTATION, 49(7), 887-894 [10.1038/bmt.2014.72]. Dettagli
  101. Sollazzo, F., Tendas, A., Conte, E., Bianchi, M.P., Niscola, P., Cupelli, L., et al. (2014). Bone marrow aspiration and biopsy-related pain management. ANNALS OF HEMATOLOGY, 93(6), 1061-1062 [10.1007/s00277-013-1926-7]. Dettagli
  102. Ruggeri, A., Sanz, G., Bittencourt, H., Sanz, J., Rambaldi, A., Volt, F., et al. (2014). Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT. LEUKEMIA, 28(4), 779-786 [10.1038/leu.2013.259]. Dettagli
  103. Labopin, M., Gorin, N., Polge, E., Socié, G., Gurman, G., Gluckman, E., et al. (2014). A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. BONE MARROW TRANSPLANTATION, 49(3), 376-381 [10.1038/bmt.2013.178]. Dettagli
  104. Scerpa, M.C., Rossi, C., Daniele, N., Lanti, A., Adorno, G., Picardi, A., et al. (2014). A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant. TRANSFUSION, 54(3), 522-531 [10.1111/trf.12307]. Dettagli
  105. Marchesi, F., Mengarelli, A., Giannotti, F., Tendas, A., Anaclerico, B., Porrini, R., et al. (2014). High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. TRANSPLANT INFECTIOUS DISEASE, 16(1), 158-164 [10.1111/tid.12162]. Dettagli
  106. Piñana, J.L., Sanz, J., Picardi, A., Ferrá, C., Martino, R., Barba, P., et al. (2014). Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. HAEMATOLOGICA, 99(2), 378-384 [10.3324/haematol.2013.091009]. Dettagli
  107. Eapen, M., Klein, J.P., Ruggeri, A., Spellman, S., Lee, S.J., Anasetti, C., et al. (2014). Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. BLOOD, 123(1), 133-140 [10.1182/blood-2013-05-506253]. Dettagli
  108. Cunha, R., Loiseau, P., Ruggeri, A., Sanz, G., Michel, G., Iori, A.P., et al. (2014). Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis. BONE MARROW TRANSPLANTATION, 49(1), 24-29 [10.1038/bmt.2013.120]. Dettagli
  109. Chuna, R., Loiseau, P., Ruggeri, A., Sanz, G., Michel, G., Paolaiori, A., et al. (2014). Impact of HLA mismatch direction on outcome after umbilical cord blood transplantation for hematological malignant disorders: a retrospective eurocord-EBMT analysis. BONE MARROW TRANSPLANTATION, 120, 1-6. Dettagli
  110. Cudillo, L., Ceresoli, E., Sarmati, L., Mariotti, B., Viscione, M., De Majo, A., et al. (2014). Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. BONE MARROW TRANSPLANTATION, 49(4), 595-596. Dettagli
  111. Girmenia, C., Raiola, A., Piciocchi, A., Algarotti, A., Stanzani, M., CUDILLO, L., et al. (2014). Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(6), 872. Dettagli
  112. Marchesi, F., Mengarelli, A., Giannotti, F., Tendas, A., Anaclerico, B., Porrini, R., et al. (2014). High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. TRANSPLANT INFECTIOUS DISEASE, 16, 158 [doi: 10.1111/tid.12162]. Dettagli
  113. Piñana, J.L., Sanz, J., Picardi, A., Ferrá, C., Rodrigo Martino, R., Barba, P., et al. (2014). Umbilical Cord Blood Transplantation From Unrelated Donors In Patients With Ph-Positive Acute Lymphoblastic Leukemia. HAEMATOLOGICA, 99, 378-392. Dettagli
  114. Scerpa, M., Rossi, C., Daniele, N., Lanti, A., Adorno, G., Picardi, A., et al. (2014). A new system for quality control in hematopoietic progenitor cell units before reinfusion in autologous transplant. TRANSFUSION, 54(3), 522-531 [10.1111/trf.12307]. Dettagli
  115. Calabrese, E., Zorzi, F., Visconti, E., De Angelis, G., Cerretti, R., Del Vecchio Blanco, G., et al. (2013). Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation. DIGESTIVE AND LIVER DISEASE, 45(11), 899-904 [10.1016/j.dld.2013.04.004]. Dettagli
  116. Todisco, E., Ciceri, F., Oldani, E., Boschini, C., Micò, C., Vanlint, M.T., et al. (2013). The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo. LEUKEMIA, 27(10), 2086-2091 [10.1038/leu.2013.208]. Dettagli
  117. Sanz, J., Picardi, A., Hernández Boluda, J.C., Martín, C., Ferrá, C., Nozzoli, C., et al. (2013). Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(9), 1387-1392 [10.1016/j.bbmt.2013.07.004]. Dettagli
  118. Porrovecchio, R., Babakir-Mina, M., Rapanotti, M., Arcese, W., Perno, C., & Ciotti, M. (2013). Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients. JOURNAL OF MEDICAL VIROLOGY, 85(6), 1122-1124 [10.1002/jmv.23565]. Dettagli
  119. Tendas, A., Pignatelli, A.C., Sollazzo, F., Veggia, B., Conte, E., D'Apolito, A., et al. (2013). Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 45(4), e2-e3 [10.1016/j.jpainsymman.2012.12.007]. Dettagli
  120. Maramattom, L.V., Hari, P.N., Burns, L.J., Carreras, J., Arcese, W., Cairo, M.S., et al. (2013). Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), 173-179 [10.1016/j.bbmt.2012.11.016]. Dettagli
  121. Di Bartolomeo, P., Santarone, S., De Angelis, G., Picardi, A., Cudillo, L., Cerretti, R., et al. (2013). Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. BLOOD, 121(5), 849-857 [10.1182/blood-2012-08-453399]. Dettagli
  122. Roos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., et al. (2013). Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. BLOOD, 121(3), 440-446 [10.1182/blood-2012-08-448613]. Dettagli
  123. Tendas, A., Sollazzo, F., Niscola, P., Cupelli, L., Mauroni, M.R., D'Apolito, A., et al. (2013). Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score. SUPPORTIVE CARE IN CANCER, 21(1), 5-6 [10.1007/s00520-012-1550-4]. Dettagli
  124. Di Bartolomeo, P., Santarone, S., De Angelis, G., Picardi, A., Cudillo, L., Cerretti, R., et al. (2013). Haploidentical, unmanipulated,G-CSF primed bona marrow transplantation for patients with high risk hematological malignancies. BLOOD, 121, 849-857 [10.1182/blood-2012-08-453399]. Dettagli
  125. Sanz, J., Picardi, A., Hernández Boluda, J., Martín, C., Ferrá, C., Nozzoli, C., et al. (2013). Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19, 1387-1392 [10.1016/j.bbmt.2013.07.004]. Dettagli
  126. Sergiacomi, G., Gaspari, E., Taglieri, A., Meschini, A., Gisone, V., Cudillo, L., et al. (2013). 3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. LA RADIOLOGIA MEDICA, 118(1), 101-111 [10.1007/s11547-012-0796-8]. Dettagli
  127. Ramadan, S., Di Veroli, A., Camboni, A., Breccia, M., Iori, A., Aversa, F., et al. (2012). Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era. HAEMATOLOGICA [10.3324/haematol.2012.065714]. Dettagli
  128. Iori, A., Valle, V., Piciocchi, A., Meloni, G., Torelli, G., Vitale, A., et al. (2012). Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia. ANNALS OF HEMATOLOGY, 91(6), 941-948 [10.1007/s00277-011-1392-z]. Dettagli
  129. Rigacci, L., Puccini, B., Dodero, A., Iacopino, P., Castagna, L., Bramanti, S., et al. (2012). Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. ANNALS OF HEMATOLOGY, 91(6), 931-939 [10.1007/s00277-011-1395-9]. Dettagli
  130. Tendas, A., Sollazzo, F., Bruno, A., Cupelli, L., Niscola, P., Pignatelli, A., et al. (2012). Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant. SUPPORTIVE CARE IN CANCER, 20(5), 891-892 [10.1007/s00520-012-1411-1]. Dettagli
  131. Bruno, A., De Meis, I., Cantoni, F., Siniscalchi, A., Velotta, V., Tendas, A., et al. (2012). High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant. BONE MARROW TRANSPLANTATION, 47, 249-249. Dettagli
  132. Rambaldi, A., Bacigalupo, A., Fanin, R., Ciceri, F., Bonifazi, F., Falda, M., et al. (2012). Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients. LEUKEMIA, 47, 47-47 [10.1038/leu.2012.55]. Dettagli
  133. Buccisano F,, Maurillo L, ., Del Principe MI,, Del Poeta G,, Sconocchia G,, Lo-Coco F,, et al. (2012). Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. BLOOD, 119, 332-341 [10.1182/blood-2011-08-363291]. Dettagli
  134. Canossi, A., Aureli, A., Del Beato, T., Arcese, W., Papola, F., Santarone, S., et al. (2012). Assessment of donor-derived kir by sequential cDNA genotyping in non t cell depleted haploidentical stem cell transplanted patients. TISSUE ANTIGENS, 79(6), 410. Dettagli
  135. Cudillo, L., Di Veroli, A., Mariotti, B., Ceresoli, E., PICARDI, A., Cerretti, R., et al. (2012). Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma. Paper presented at 38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, SWITZERLAND. Dettagli
  136. Lanini, S., Garbuglia, A., Puro, V., Solmone, M., Martini, L., Arcese, W., et al. (2012). Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device. PLOS ONE, 7(3), e33122-e33122 [10.1371/journal.pone.0033122]. Dettagli
  137. Marchesi, F., Giannotti, F., Avvisati, G., Petti, M., Pimpinelli, F., Paba, P., et al. (2012). The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. AMERICAN JOURNAL OF HEMATOLOGY, 87(2), 213-217 [10.1002/ajh.22214]. Dettagli
  138. Arcese, W., Mangione, I., & Picardi, A. (2011). Algorithm for donor selection in 2011. CURRENT OPINION IN HEMATOLOGY, 18(6), 401-407 [10.1097/MOH.0b013e32834ba838]. Dettagli
  139. Marchesi, F., Giannotti, F., Avvisati, G., Petti, M., Pimpinelli, F., Paba, P., et al. (2011). The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network. ANNALS OF HEMATOLOGY [doi: 10.1002/ajh.22214]. Dettagli
  140. Tendas, A., Boschetto, C., Baraldi, L., Caiazza, E., Cupelli, L., Lentini, R., et al. (2011). Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease. INDIAN JOURNAL OF PALLIATIVE CARE, 17(2), 159-161 [10.4103/0973-1075.84540]. Dettagli
  141. Ferrannini, M., Vischini, G., De Angelis, G., Giannakakis, K., & Arcese, W. (2011). Spontaneous bilateral kidney rupture during autologous stem cell transplantation in a patient affected by amyloidosis. NDT PLUS, 4(1), 56-59 [10.1093/ndtplus/sfq168]. Dettagli
  142. Arcese, W., Picardi, A., Locatelli, F., Pinto, R.M., De Fabritiis, P., Dentamaro, T., et al. (2011). The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . BONE MARROW TRANSPLANTATION, 46. Dettagli
  143. Lanti A, Spurio SD, Ferraro AS, D’Alessandro E, Chiru OM, Fiorelli E, et al. (2011). Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network. BONE MARROW TRANSPLANTATION, 46. Dettagli
  144. Picardi, A., Lanti, A., Ferraro, A.S., Di Veroli, A., Cudillo, L., Cerretti, R., et al. (2011). Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease. BONE MARROW TRANSPLANTATION, 46(Supp. 1). Dettagli
  145. Santarone, S., Di Bartolomeo, P., De Angelis, G., Picardi, A., Bavaro, P., Di Bartolomeo, E., et al. (2011). Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies. BONE MARROW TRANSPLANTATION, 46(supp. 1), 349-349. Dettagli
  146. Duarte, R.F., Canals, C., Onida, F., Gabriel, I.H., Arranz, R., Arcese, W., et al. (2010). Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. JOURNAL OF CLINICAL ONCOLOGY, 28(29), 4492-4499 [10.1200/JCO.2010.29.3241]. Dettagli
  147. Di Veroli, A., Ramadan, S.M., Divona, M., Cudillo, L., Giannì, L., Wieland, S., et al. (2010). Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene. BRITISH JOURNAL OF HAEMATOLOGY, 151(1), 99-101 [10.1111/j.1365-2141.2010.08308.x]. Dettagli
  148. Zinno, F., Landi, F., Aureli, V., Caniglia, M., Pinto, R.M., Rana, I., et al. (2010). Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures. TRANSFUSION AND APHERESIS SCIENCE, 43(2), 173-178 [10.1016/j.transci.2010.07.005]. Dettagli
  149. Dragoni, F., Iori, A., Pignoloni, P., Minotti, C., Chiarotti, F., Mazzucconi, M., et al. (2010). Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study. BRITISH JOURNAL OF HAEMATOLOGY, 150(4), 492-494 [10.1111/j.1365-2141.2010.08230.x]. Dettagli
  150. Picardi, A., & Arcese, W. (2010). Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. TRANSFUSION AND APHERESIS SCIENCE, 42(3), 289-297 [10.1016/j.transci.2010.03.004]. Dettagli
  151. Sarmati, L., Beltrame, A., Dori, L., Maffongelli, G., Cudillo, L., De Angelis, G., et al. (2010). Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. AMERICAN JOURNAL OF HEMATOLOGY, 85(5), 380-383 [10.1002/ajh.21685]. Dettagli
  152. Sarmati, L., Beltrame, A., Dori, L., Maffongelli, G., Cudillo, L., De Angelis, G., et al. (2010). Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. AMERICAN JOURNAL OF HEMATOLOGY, 85(5), 380-383 [10.1002/ajh.21685]. Dettagli
  153. Arcese, W., Buccisano, F., Cerretti, R., & Picardi, A. (2010). Cord blood transplantation in adults with acute myeloid leukaemia. BAILLIERE'S BEST PRACTICE IN CLINICAL HAEMATOLOGY, 23, 197-206 [10.1016/j.beha.2010.05.007]. Dettagli
  154. Buccisano, F., Maurillo, L., Spagnoli, A., Del Principe, M.I., Fraboni, D., Panetta, P., et al. (2010). Cytogenetic and molecular diagnostic characterization combined to post-consolidation minimal residual disease assessment by flow-cytometry improves risk stratification in adult acute myeloid leukemia. BLOOD, 116, 2295-2303. Dettagli
  155. Cudillo, L., Cerretti, R., Picardi, A., Mirabile, M., Giannotti, F., De Angelis, G., et al. (2010). Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. BONE MARROW TRANSPLANTATION, 45. Dettagli
  156. DRAGONI, F., IORI ANNA, P., PIGNOLONI, P., MINOTTI, C., CHIAROTTI, F., MAZZUCCONI MARIA, G., et al. (2010). Antiphospholipid Antibodies and Thrombotic Complications In Patients With Paroxysmal Nocturnal Hemoglobinuria. BRITISH JOURNAL OF HAEMATOLOGY, 150, 492-494. Dettagli
  157. GORIN, N., LABOPIN, M., REIFFERS, J., MILPIED, N., BLAISE, D., WITZ, F., et al. (2010). Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. BLOOD, 116, 3157-3162 [10.1182/blood-2009-11-252197]. Dettagli
  158. Kyriakou, C., Canals, C., Sibon, D., Cahn, Y., Kazmi, M., Arcese, W., et al. (2010). High-dose therapy and autologous stem-cell transplantation in waldenstrom macroglobulinemia: the lymphoma working party of the european group for blood and marrow transplantation. JOURNAL OF CLINICAL ONCOLOGY, 28, 2227-2232 [10.1200/JCO.2009.24.4905]. Dettagli
  159. Mary, E., Vanderson, R., Guillermo, S., Andromachi, S., Mei-Jie, Z., Arcese, W., et al. (2010). Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis. THE LANCET ONCOLOGY, 11, 653-660 [10.1016/S1470-2045(10)70127-3]. Dettagli
  160. Picardi, A., & Arcese, W. (2010). Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. TRANSFUSION AND APHERESIS SCIENCE, 42, 289-297 [10.1016/j.transci.2010.03.004]. Dettagli
  161. Picardi, A., De Fabritiis, P., Dentamaro, T., De Rossi, G., Caniglia, M., Petti, M.C., et al. (2010). The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network. BONE MARROW TRANSPLANTATION, 45. Dettagli
  162. Picardi, A., Lanti, A., Cudillo, L., Cerretti, R., Dentamaro, T., DE ANGELIS, G., et al. (2010). Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. TRANSFUSION, 50(2), 501-506 [10.1111/j.1537-2995.2009.02439.x]. Dettagli
  163. Picardi, A., Lanti, A., Cudillo, L., Cerretti, R., Dentamaro, T., De Angelis, G., et al. (2010). Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. TRANSFUSION, 50, 501-506. Dettagli
  164. ROMEO, A., CHIERICHINI, A., SPAGNOLI, A., VITTORI, M., VACCA, M., GOZZER, M., et al. (2010). Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization. TRANSFUSION, 50, 2432-2446 [10.1111/j.1537-2995.2010.02723.x]. Dettagli
  165. Tirindelli, M.C., Flammia, M., Cudillo, L., Dentamaro, T. .P., Annibali, O., Tendas, A., et al. (2010). Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant. BONE MARROW TRANSPLANTATION, 45(Supp. 2), 12-12. Dettagli
  166. Zinno, F., Landi, F., Aureli, V., Caniglia, M., Pinto, R., Rana, I., et al. (2010). Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures. TRANSFUSION AND APHERESIS SCIENCE, 43(2), 173-178 [10.1016/j.transci.2010.07.005]. Dettagli
  167. Beltrame, A., Sarmati, L., Cudillo, L., Cerretti, R., Picardi, A., Anemona, L., et al. (2009). A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13(6), 488-492 [10.1016/j.ijid.2009.01.020]. Dettagli
  168. Beltrame, A., Sarmati, L., Cudillo, L., Cerretti, R., Picardi, A., Anemona, L., et al. (2009). A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13(6), e488-e492 [10.1016/j.ijid.2009.01.020]. Dettagli
  169. Babakir-Mina, M., Ciccozzi, M., Alteri, C., Polchi, P., Picardi, A., Greco, F., et al. (2009). Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. JOURNAL OF MEDICAL VIROLOGY, 81(9), 1668-1673. Dettagli
  170. Crocchiolo, R., Zino, E., Vago, L., Oneto, R., Bruno, B., Pollichieni, S., et al. (2009). Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. BLOOD, 114(7), 1437-1444 [10.1182/blood-2009-01-200378]. Dettagli
  171. Cesaro, S., Hirsch, H., Faraci, M., Owoc-Lempach, J., Beltrame, A., Tendas, A., et al. (2009). Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. CLINICAL INFECTIOUS DISEASES, 49(2), 233-240 [10.1086/599829]. Dettagli
  172. Cudillo, L., Cerretti, R., Baliva, G., De Angelis, G., Postorino, M., Picardi, A., et al. (2009). Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion. BONE MARROW TRANSPLANTATION, 43(4), 347-348 [10.1038/bmt.2008.333]. Dettagli
  173. Tirindelli, M., Flammia, G., Sergi, F., Cerretti, R., Cudillo, L., Picardi, A., et al. (2009). Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation. TRANSFUSION, 49(1), 170-175 [10.1111/j.1537-2995.2008.01934.x]. Dettagli
  174. Tirindelli, M.C., Flammia, G., Sergi, F., Cerretti, R., Cudillo, L., Picardi, A., et al. (2009). Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation. TRANSFUSION, 49(1), 170-175 [10.1111/j.1537-2995.2008.01934.x]. Dettagli
  175. Arcese, W., Cudillo, L., & Picardi, A. (2009). Il Trapianto di Cellule Stminali Emopoietiche.. In Il Trapianto di Cellule Stminali Emopoietiche. (pp. 1-11). SEU. Dettagli
  176. Babakir Mina, M., Ciccozzi, M., Alteri, C., Polchi, P., Picardi, A., Greco, F., et al. (2009). Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. JOURNAL OF MEDICAL VIROLOGY, 81(9), 1668-1673 [10.1002/jmv.21559]. Dettagli
  177. Buccisano, F., Maurillo, L., Spagnoli, A., Del Principe, M., Ceresoli, E., Lo Coco, F., et al. (2009). Monitoring of minimal residual disease in acute myeloid leukemia. CURRENT OPINION IN ONCOLOGY, 21, 582-588. Dettagli
  178. Cudillo, L., Cerretti, R., Baliva, G., De Angelis, G., Postorino, M., Picardi, A., et al. (2009). Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion. BONE MARROW TRANSPLANTATION, 43(4), 347-348 [10.1038/bmt.2008.333]. Dettagli
  179. Cudillo, L., Cerretti, R., Picardi, A., Mirabile, M., Giannotti, F., Mariotti, B., et al. (2009). Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. HAEMATOLOGICA, 94(s4). Dettagli
  180. Lupattelli, M., Marchetti, G., POSTORINO, M., Franceschini, L., Romeo, N., CUDILLO, L., et al. (2009). Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. NUTRITIONAL THERAPY & METABOLISM, 27, 39-45. Dettagli
  181. Ottaviani, L., Sarlo, C., Ceresoli, E., Cefalo, M., Zottolo, R., Campagna, S., et al. (2009). Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia. HAEMATOLOGICA, 94. Dettagli
  182. PICARDI, A., DE FABRITIIS, P., Dentamaro, T., De Rossi, G., Caniglia, M., Pinto Petti, M., et al. (2009). The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. HAEMATOLOGICA, 94. Dettagli
  183. Picardi, A., Spagnoli, A., Caniglia, M., Pinto, R., Dentamaro, T., Mangione, I., et al. (2009). Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant. BONE MARROW TRANSPLANTATION, 43(Supp. 1). Dettagli
  184. Vischini, G., Cudillo, L., Ferrannini, M., Di Daniele, N., Cerretti, R., & Arcese, W. (2009). Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report. JN. JOURNAL OF NEPHROLOGY, 22, 160-163. Dettagli
  185. Maurillo, L., Buccisano, F., Del Principe, M.I., Del Poeta, G., Spagnoli, A., Panetta, P., et al. (2008). Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia. JOURNAL OF CLINICAL ONCOLOGY, 26(30), 4944-4951 [10.1200/JCO.2007.15.9814]. Dettagli
  186. Alessandrino, E., Della Porta, M., Bacigalupo, A., Van Lint, M., Falda, M., Onida, F., et al. (2008). WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). BLOOD, 112(3), 895-902 [10.1182/blood-2008-03-143735]. Dettagli
  187. Iori, A., Arcese, W., Milano, F., Calabrese, E., Torelli, G., Barberi, W., et al. (2007). Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up. HAEMATOLOGICA, 92(8), 1051-1058 [10.3324/haematol.11271]. Dettagli
  188. Screnci, M., Salvatori, S., Carmini, D., & Arcese, W. (2007). Does the volume reduction manipulation before cryopreservation influence cord blood cell recovery pretransplant?. TRANSFUSION MEDICINE, 17(3), 208-209 [10.1111/j.1365-3148.2007.00749.x]. Dettagli
  189. Sanz, M., Labopin, M., Gorin, N., de la Rubia, J., Arcese, W., Meloni, G., et al. (2007). Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation. BONE MARROW TRANSPLANTATION, 39(8), 461-469 [10.1038/sj.bmt.1705620]. Dettagli
  190. Herr, A., Labopin, M., Blaise, D., Milpied, N., Potter, M., Michallet, M., et al. (2007). HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia. LEUKEMIA, 21(1), 129-135 [10.1038/sj.leu.2404461]. Dettagli
  191. Arcese, W., Rocha, V., Labopin, M., Sanz, G., Iori, A., de Lima, M., et al. (2006). Unrelated cord blood transplants in adults with hematologic malignancies. HAEMATOLOGICA, 91(2), 223-230. Dettagli
  192. Arcese, W., Picardi, A., Cerretti, R., Cudillo, L., DE ANGELIS, G., Franceschini, L., et al. (2006). The therapeutic use of cord blood. CELL PRESERVATION TECHNOLOGY, 4(3), 161-168 [10.1089/cpt.2006.4.161]. Dettagli
  193. Van Lint, M., Milone, G., Leotta, S., Uderzo, C., Scime, R., Dallorso, S., et al. (2006). Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. BLOOD, 107(10), 4177-4181 [10.1182/blood-2005-12-4851]. Dettagli
  194. De Felice, L., Tatarelli, C., Mascolo, M., Gregorj, C., Agostini, F., Fiorini, R., et al. (2005). Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. CANCER RESEARCH, 65(4), 1505-1513 [10.1158/0008-5472.CAN-04-3063]. Dettagli
  195. Caronna, R., Cardi, M., Arcese, W., Iori, A., Martelli, M., Catinelli, S., et al. (2005). Gastrointestinal surgical emergencies in patients treated for hemathological malignancies. I SUPPLEMENTI DI TUMORI, 4(3), 141-145. Dettagli
  196. Locasciulli, A., Bruno, B., Rambaldi, A., Saracco, P., Dufour, C., Finelli, C., et al. (2004). Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. HAEMATOLOGICA, 89(9), 1054-1061. Dettagli
  197. Raimondi, R., Soli, M., Lamparelli, T., Bacigalupo, A., Arcese, W., Belloni, M., et al. (2004). ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. BONE MARROW TRANSPLANTATION, 34(4), 321-329 [10.1038/sj.bmt.1704579]. Dettagli
  198. Iori, A., Cerretti, R., De Felice, L., Screnci, M., Mengarelli, A., Romano, A., et al. (2004). Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. BONE MARROW TRANSPLANTATION, 33(11), 1097-1105 [10.1038/sj.bmt.1704500]. Dettagli
  199. Gluckman, E., Rocha, V., Arcese, W., Michel, G., Sanz, G., Chan, K., et al. (2004). Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. EXPERIMENTAL HEMATOLOGY, 32(4), 397-407 [10.1016/j.exphem.2004.01.002]. Dettagli
  200. Ringdén, O., Labopin, M., Gorin, N., Le Blanc, K., Rocha, V., Gluckman, E., et al. (2004). Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. JOURNAL OF CLINICAL ONCOLOGY, 22(3), 416-423 [10.1200/JCO.2004.06.102]. Dettagli
  201. Letizia, C., Celi, M., Iori, A., Verrelli, C., Caliumi, C., Diacinti, D., et al. (2004). Bone mass, bone metabolism, and prevalence of spinal fractures in recipients of allogenic bone marrow transplantation for leukemia. ANNALI ITALIANI DI MEDICINA INTERNA, 19(3), 175-183. Dettagli
  202. Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., et al. (2004). Transplants of Umbilical Cord Blood or Bone Marrow from Unrelated donors in Adult with Acute Leukemia. NEW ENGLAND JOURNAL OF MEDICINE, 351, 2276-2285 [10.1056/NEJMoa041469]. Dettagli
  203. Michel, G., Rocha, V., Chevret, S., Arcese, W., Chan, K., Filipovich, A., et al. (2003). Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. BLOOD, 102(13), 4290-4297 [10.1182/blood-2003-04-1288]. Dettagli
  204. Gorin, N., Labopin, M., Rocha, V., Arcese, W., Beksac, M., Gluckman, E., et al. (2003). Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. BLOOD, 102(8), 3043-3051 [10.1182/blood-2003-03-0665]. Dettagli
  205. Lo-Coco, F., Romano, A., Mengarelli, A., Diverio, D., Iori, A., Moleti, M., et al. (2003). Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease. LEUKEMIA, 17(10), 1930-1933 [10.1038/sj.leu.2403078]. Dettagli
  206. Cwynarski, K., Roberts, I., Iacobelli, S., van Biezen, A., Brand, R., Devergie, A., et al. (2003). Stem cell transplantation for chronic myeloid leukemia in children. BLOOD, 102(4), 1224-1231 [10.1182/blood-2002-12-3637]. Dettagli
  207. Dini, G., Valsecchi, M., Micalizzi, C., Busca, A., Balduzzi, A., Arcese, W., et al. (2003). Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission. BONE MARROW TRANSPLANTATION, 32(3), 325-331 [10.1038/sj.bmt.1704132]. Dettagli
  208. Del Giudice, I., Iori, A., Mengarelli, A., Testi, A., Romano, A., Cerretti, R., et al. (2003). Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. ANNALS OF HEMATOLOGY, 82(3), 189-192 [10.1007/s00277-002-0590-0]. Dettagli
  209. Mengarelli, A., Iori, A., Romano, A., Cerretti, R., Cerilli, L., De Propris, M., et al. (2003). One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. HAEMATOLOGICA, 88(3), 315-323. Dettagli
  210. Locasciulli, A., Bruno, B., Alessandrino, E., Meloni, G., Arcese, W., Bandini, G., et al. (2003). Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. BONE MARROW TRANSPLANTATION, 31(4), 295-300 [10.1038/sj.bmt.1703826]. Dettagli
  211. Ringdén, O., Labopin, M., Bacigalupo, A., Arcese, W., Schaefer, U., Willemze, R., et al. (2002). Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. JOURNAL OF CLINICAL ONCOLOGY, 20(24), 4655-4664 [10.1200/JCO.2002.12.049]. Dettagli
  212. Rocha, V., Labopin, M., Gluckman, E., Powles, R., Arcese, W., Bacigalupo, A., et al. (2002). Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey. JOURNAL OF CLINICAL ONCOLOGY, 20(21), 4324-4330 [10.1200/JCO.2002.11.058]. Dettagli
  213. Testi, A., Del Giudice, I., Arcese, W., Moleti, M., Giona, F., Basso, G., et al. (2002). A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. BRITISH JOURNAL OF HAEMATOLOGY, 118(3), 741-747 [10.1046/j.1365-2141.2002.03706.x]. Dettagli
  214. Dini, G., Cancedda, R., Giorgiani, G., Porta, F., Messina, C., Uderzo, C., et al. (2002). Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO). HAEMATOLOGICA, 87(8 Suppl), 51-57. Dettagli
  215. Guglielmi, C., Arcese, W., Dazzi, F., Brand, R., Bunjes, D., Verdonck, L., et al. (2002). Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. BLOOD, 100(2), 397-405 [10.1182/blood.V100.2.397]. Dettagli
  216. Mengarelli, A., Iori, A., Cerretti, R., Cerilli, L., Romano, A., & Arcese, W. (2002). Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy. HAEMATOLOGICA, 87(7), 782-784. Dettagli
  217. Bonifazi, F., Bandini, G., & Arcese, W. (2002). Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow transplantation. HAEMATOLOGICA, 87(5), 449-452. Dettagli
  218. Mengarelli, A., Iori, A., Guglielmi, C., Romano, A., Cerretti, R., Torromeo, C., et al. (2002). Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. HAEMATOLOGICA, 87(1), 52-58. Dettagli
  219. Rocha, V., Cornish, J., Sievers, E., Filipovich, A., Locatelli, F., Peters, C., et al. (2001). Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. BLOOD, 97(10), 2962-2971 [10.1182/blood.V97.10.2962]. Dettagli
  220. Dini, G., Cancedda, R., Locatelli, F., Bosi, A., Bandini, G., Alessandrino, E., et al. (2001). Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO). HAEMATOLOGICA, 86(5), 451-456. Dettagli
  221. de Fabritiis, P., Iori, A., Mengarelli, A., Gozzer, M., Ferrazza, G., De Propris, M., et al. (2001). CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF. TRANSFUSION, 41(2), 190-195 [10.1046/j.1537-2995.2001.41020190.x]. Dettagli
  222. Locasciulli, A., Arcese, W., Locatelli, F., Di Bona, E., & Bacigalupo, A. (2001). Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. THE LANCET, 357(9249), 43-44 [10.1016/S0140-6736(00)03574-1]. Dettagli
  223. Mengarelli, A., Iori, A., Guglielmi, C., Perrone, M., Gozzer, M., Girmenia, C., et al. (2000). Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies. LEUKEMIA, 14(12), 2052-2058 [10.1038/sj.leu.2401947]. Dettagli
  224. Dini, G., Cancedda, R., Locatelli, F., Bosi, A., Bandini, G., Alessandrino, E., et al. (2000). Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO). HAEMATOLOGICA, 85(11 Suppl), 30-36. Dettagli
  225. Locatelli, F., Bruno, B., Zecca, M., Van-Lint, M., McCann, S., Arcese, W., et al. (2000). Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. BLOOD, 96(5), 1690-1697. Dettagli
  226. Girmenia, C., Iori, A., Bernasconi, S., Testi, A., Moleti, M., Arcese, W., et al. (2000). Listeriosis in recipients of allogeneic bone marrow transplants from unrelated donors. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 19(9), 711-714 [10.1007/s100960000343]. Dettagli
  227. Guglielmi, C., Arcese, W., Hermans, J., Bacigalupo, A., Bandini, G., Bunjes, D., et al. (2000). Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. BLOOD, 95(11), 3328-3334. Dettagli
  228. Frassoni, F., Labopin, M., Powles, R., Mary, J., Arcese, W., Bacigalupo, A., et al. (2000). Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. THE LANCET, 355(9213), 1393-1398 [10.1016/S0140-6736(00)02137-1]. Dettagli
  229. Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locasciulli, A., Locatelli, F., et al. (2000). Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). BLOOD, 95(6), 1931-1934. Dettagli
  230. Guardiola, P., Pasquini, R., Dokal, I., Ortega, J., van Weel-Sipman, M., Marsh, J., et al. (2000). Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. BLOOD, 95(2), 422-429. Dettagli
  231. Mengarelli, A., Minotti, C., Palumbo, G., Arcieri, P., Gentile, G., Iori, A., et al. (2000). High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation. BRITISH JOURNAL OF HAEMATOLOGY, 108(1), 126-131 [10.1046/j.1365-2141.2000.01812.x]. Dettagli
  232. Arcese, W., & Guglielmi, C. (2000). Survival of patients with PH+ Chronic myeloid leukemia relapsing after an allogeneic stem cell transplant.. Paper presented at The Jubilee Meeting on CML, Bologna. Dettagli
  233. Colombo, A., Alessandrino, E., Bernasconi, P., Arcese, G., Rabusin, M., Bacigalupo, A., et al. (1999). N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). TRANSPLANTATION, 68(9), 1414-1416 [10.1097/00007890-199911150-00031]. Dettagli
  234. De Felice, L., Di Pucchio, T., Mascolo, M., Agostini, F., Breccia, M., Guglielmi, C., et al. (1999). Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures. BRITISH JOURNAL OF HAEMATOLOGY, 106(1), 133-141 [10.1046/j.1365-2141.1999.01519.x]. Dettagli
  235. Iacopino, P., Pucci, G., Arcese, W., Bosi, A., Falda, M., Locatelli, F., et al. (1999). Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO). BONE MARROW TRANSPLANTATION, 24(1), 47-51 [10.1038/sj.bmt.1701830]. Dettagli
  236. Locatelli, F., Rocha, V., Chastang, C., Arcese, W., Michel, G., Abecasis, M., et al. (1999). Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. BLOOD, 93(11), 3662-3671. Dettagli
  237. Arcese, W., Tura, S., Russo, D., Baccarani, M., Fanin, R., Tiribelli, M., et al. (1999). Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation. JOURNAL OF CLINICAL ONCOLOGY, 17(6), 1858-1868. Dettagli
  238. Elia, L., Arcese, W., Torello, M., Iori, A., Guglielmi, C., Perrone, M., et al. (1999). HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants. HAEMATOLOGICA, 84(6), 530-534. Dettagli
  239. Guardiola, P., Anderson, J., Bandini, G., Cervantes, F., Runde, V., Arcese, W., et al. (1999). Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. BLOOD, 93(9), 2831-2838. Dettagli
  240. Arcese, W., & Iori, A. (1999). Pregnancy and secondary cancer after allogeneic bone marrow transplantation. BONE MARROW TRANSPLANTATION, 23(7), 752-752 [10.1038/sj.bmt.1701653]. Dettagli
  241. Arcese, W., Guglielmi, C., Iori, A., Screnci, M., Carmini, D., Testi, A., et al. (1999). Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemia. BONE MARROW TRANSPLANTATION, 23(6), 549-554 [10.1038/sj.bmt.1701615]. Dettagli
  242. Cimino, G., Rapanotti, M., Elia, L., Iori, A., Guglielmi, C., Screnci, M., et al. (1999). A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients. BRITISH JOURNAL OF HAEMATOLOGY, 104(4), 770-777 [10.1046/j.1365-2141.1999.01232.x]. Dettagli
  243. Dini, G., Arcese, W., Barbanti, M., Biffoni, F., Bosi, A., Lanino, E., et al. (1998). Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant. BONE MARROW TRANSPLANTATION, 22 Suppl 5, S41-S41-5. Dettagli
  244. Giona, F., Annino, L., Testi, A., Rondelli, R., Arcese, W., Meloni, G., et al. (1998). Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups. LEUKEMIA & LYMPHOMA, 32(1-2), 89-95 [10.3109/10428199809059249]. Dettagli
  245. Carreras, E., Bertz, H., Arcese, W., Vernant, J., Tomás, J., Hagglund, H., et al. (1998). Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. BLOOD, 92(10), 3599-3604. Dettagli
  246. Gratwohl, A., Hermans, J., Goldman, J., Arcese, W., Carreras, E., Devergie, A., et al. (1998). Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. THE LANCET, 352(9134), 1087-1092 [10.1016/S0140-6736(98)03030-X]. Dettagli
  247. Van Lint, M., Uderzo, C., Locasciulli, A., Majolino, I., Scimé, R., Locatelli, F., et al. (1998). Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. BLOOD, 92(7), 2288-2293. Dettagli
  248. Muscaritoli, M., Conversano, L., Torelli, G., Arcese, W., Capria, S., Cangiano, C., et al. (1998). Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. TRANSPLANTATION, 66(5), 610-616 [10.1097/00007890-199809150-00011]. Dettagli
  249. Donato, V., Iacari, V., Zurlo, A., Capua, A., Tombolini, V., Banelli, E., et al. (1998). Fractionated total body irradiation in allogeneic bone marrow transplantation in leukemia patients: analysis of prognostic factors and results in 136 patients. RADIOTHERAPY AND ONCOLOGY, 48(3), 267-276 [10.1016/S0167-8140(98)00069-3]. Dettagli
  250. Iori, A., Screnci, M., Guglielmi, C., Mengarelli, A., Carmini, D., Testi, A., et al. (1998). Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemia. BONE MARROW TRANSPLANTATION, 22 Suppl 1, S75-S75. Dettagli
  251. Giona, F., Testi, A.M., Rondelli, R., Amadori, S., Arcese, W., Meloni, G., et al. (1997). ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse. BRITISH JOURNAL OF HAEMATOLOGY, 99(3), 671-677. Dettagli
  252. Vitale, A., Testi, A.m., Moleti, M.l., Vignetti, M., Arcese, W., Fenu, S., et al. (1994). Myelodysplastic syndromes in childhood: description of seven cases. ANNALS OF HEMATOLOGY, 68(5), 241-5. Dettagli
  253. Gentile, G., Venditti, M., Micozzi, A., Caprioli, A., Donelli, G., Tirindelli, C., et al. (1991). Cryptosporidiosis in patients with hematologic malignancies. REVIEWS OF INFECTIOUS DISEASES, 13(5), 842-846. Dettagli
  254. Sarmati, L., Andreoni, M., Arcese, W., Pica, F., Bianchi, A., Mauro, F., et al. (1987). L'infezione da Citomegalovirus in 16 pazienti sottoposti a trapianto di midollo. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE, 39, 935-936. Dettagli
  255. Petti, M., Amadori, S., Annino, L., Arcese, W., Avvisati, G., Di Lorenzo, A., et al. (1982). Clinical and biological aspects of acute monocytic leukemia (a retrospective study of 29 patients). HAEMATOLOGICA, 67(4), 556-566. Dettagli
  256. Tribalto, M., Pastore, S., Colombo, R., Arcese, W., & Mandelli, F. (1981). Smouldering multiple myeloma. HAEMATOLOGICA, 66(6), 880-882. Dettagli
  257. Gluckman, E., Barrett, A., Arcese, W., Devergie, A., & Degoulet, P. (1981). Bone marrow transplantation in severe aplastic anaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.). BRITISH JOURNAL OF HAEMATOLOGY, 49(2), 165-173 [10.1111/j.1365-2141.1981.tb07212.x]. Dettagli